Gentiva Health Services
The 10-second takeaway
For the quarter ended Sep. 30 (Q3), Gentiva Health Services met expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue shrank and GAAP loss per share contracted.
Margins grew across the board.
Gentiva Health Services reported revenue of $424.4 million. The seven analysts polled by S&P Capital IQ expected a top line of $428.4 million on the same basis. GAAP reported sales were 5.6% lower than the prior-year quarter's $449.7 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.32. The seven earnings estimates compiled by S&P Capital IQ predicted $0.28 per share. GAAP EPS were -$0.02 for Q3 compared to -$15.62 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 47.3%, 130 basis points better than the prior-year quarter. Operating margin was 9.3%, 170 basis points better than the prior-year quarter. Net margin was -0.1%, 10,520 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $433.4 million. On the bottom line, the average EPS estimate is $0.33.
Next year's average estimate for revenue is $1.72 billion. The average EPS estimate is $1.25.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 276 members out of 298 rating the stock outperform, and 22 members rating it underperform. Among 91 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 85 give Gentiva Health Services a green thumbs-up, and six give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Gentiva Health Services is hold, with an average price target of $12.75.
- Add Gentiva Health Services to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
The Only Book Value Bargain in the Healthcare Sector and Why You Should Avoid It
Based on book value this is the cheapest stock in the healthcare sector. However, just because it's cheap doesn't mean you'll want anything to do with it.
3 Stocks Near 52-Week Highs Worth Selling
Are these three stocks sells or belles? You be the judge!
What Sparked Gentiva Health Services, Inc. Stock's Surprising Surge
Gentiva shares soar after igniting a supposed bidding war for the company. Find out what this means for Gentiva's shareholders.